Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug
Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol
Read the full story at source →
Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol
Read the full story at source →
Post Comment